AssureCKD, a Canadian medical device company developing point-of-care solutions for chronic kidney disease (CKD) screening and diagnosis, today announced the appointment of Dr. Aman Khan as Chief ...

B-type natriuretic peptide shows a graded association with decline in kidney function in individuals with diabetes, even at concentrations ≤ 18.4 pg/mL, which are conventionally considered normal.

Recently analyzed evidence points to a connection between oral health and kidney health, according to work led by University of Cincinnati College of Medicine researchers. Their article, published in ...

A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in ...

Prevalence estimates indicate ~35.5 million U.S. adults have CKD, with heightened cardiovascular risk, progression to kidney failure, and ~85,000 annual deaths. Economic data remain sparse, yet ...

Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.

We see chronic kidney disease (CKD) in clinics every day; it is no longer a far-off public health issue. Diabetes and ...

A 16-µg dose of lubiprostone, a medication used in the management of constipation, improved or preserved estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD), ...

The investigators closed their report by explaining that while therapies like tenapanor and SNF472 have shown promise, and ...